Veloso Mário
Hospital Egas Moniz (Centro Hospitalar de Lisboa Ocidental, EPE), Rua da Junqueira, 126, 1349-019 Lisboa, Portugal.
Mult Scler Relat Disord. 2013 Oct;2(4):377-84. doi: 10.1016/j.msard.2013.04.001. Epub 2013 May 4.
Shared decision making (SDM) is concerned with patient involvement into medical decisions and chronic conditions such as Multiple sclerosis (MS), with only partially effective treatments leading to potential severe side effects, conflicting evidence, and uncertain evidence on outcomes, constitute a typical condition for SDM. As treatment options increase and patients participate more intensively in decisions, the need for evidence-based information (EBI) becomes clear. Natural history (NH) studies of MS represent the basic sources for required EBI and are especially useful to contribute to the practical exercise of prognosis formulation and to enable the evaluation of effectiveness in the context of treatment. Several of these identify early clinical factors predictive of the course of MS but there is no consensus method for determining the long term progression of disability and evolution of individual patients on the basis of observations on the early stages of the disease, which constitutes a major challenge for the practicing neurologist. Aiming at delivering more reliable prognosis estimation, this study combines the distribution of patients reaching specific levels of disability within defined time periods as determined in NH studies, with disability curves and severity scores as a function of time, in terms of percentiles and deciles respectively, derived from longitudinal data analysis studies. A computer agent-based simulation model was implemented as a comprehensive and easy to utilize tool able to predict and monitor progression of disability in MS patients, and to support the neurologist discussing prognosis scenarios with the individual patient for effective SDM.
共同决策(SDM)关注患者参与医疗决策,而诸如多发性硬化症(MS)这类慢性病,其治疗效果仅部分有效且可能导致严重副作用,同时存在相互矛盾的证据以及关于治疗结果的不确定证据,构成了共同决策的典型情况。随着治疗选择的增加以及患者更积极地参与决策,对循证信息(EBI)的需求变得清晰起来。MS的自然史(NH)研究是所需循证信息的基本来源,尤其有助于实际进行预后评估,并在治疗背景下评估疗效。其中一些研究确定了预测MS病程的早期临床因素,但对于基于疾病早期观察结果来确定个体患者残疾的长期进展和演变,尚无共识性方法,这对神经科医生的临床实践构成了重大挑战。为了提供更可靠的预后估计,本研究将NH研究中确定的在特定时间段内达到特定残疾水平的患者分布情况,与分别从纵向数据分析研究中得出的作为时间函数的残疾曲线和严重程度评分(分别以百分位数和十分位数表示)相结合。实施了一个基于计算机智能体的模拟模型,作为一个全面且易于使用的工具,能够预测和监测MS患者的残疾进展,并支持神经科医生与个体患者讨论预后情况以实现有效的共同决策。